Ebola virus disease
Shevin T. Jacob(Liverpool School of Tropical Medicine), Jens H. Kuhn(National Institute of Allergy and Infectious Diseases)
Cited by 634
Related Papers
Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties
|JCI Insight|2021|20
Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry
|bioRxiv (Cold Spring Harbor Laboratory)|2018|0